Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDyda Aen
dc.contributor.authorMcGregor Sen
dc.contributor.authorBinks Pen
dc.contributor.authorDavies Jen
dc.contributor.authorTong SYen
dc.contributor.authorKrause Ven
dc.contributor.authorMarkey Pen
dc.contributor.authorQin Li SLen
dc.contributor.authorDavis JSen
dc.contributor.authorKaldor JMen
dc.contributor.authorLiu Ben
dc.identifier.citation© Commonwealth of Australia CC BY-NC-ND.en
dc.identifier.citationCommun Dis Intell (2018). 2022 Sep 26;46. doi: 10.33321/cdi.2022.46.62.en
dc.description.abstractBACKGROUND: Hepatitis B virus (HBV) vaccination in the Northern Territory (NT) was funded for all Aboriginal and Torres Strait Islander newborns in 1988 and for all newborns in 1990. The prevalence of HBV in the Northern Territory was found to be higher in Aboriginal and Torres Strait Islander women than in non-Indigenous women across 2005-2010. We examined more recent data to assess whether the gap remains. METHODS: We linked data from two routinely collected registries, the NT Perinatal Register and the NT Notifiable Diseases System, to investigate the prevalence of HBV infection, according to eligibility for infant HBV vaccination, in women giving birth during 2005-2015. RESULTS: There were 22,781 women recorded as giving birth in public hospitals in the Northern Territory during 2005-2015. Hepatitis B virus prevalence was highest in Aboriginal and Torres Strait Islander (1.8%) and overseas-born women (1.8%). Among Aboriginal and Torres Strait Islander women, estimated hepatitis B virus prevalence was significantly higher in those born before the implementation of the vaccination program than in those born afterwards (2.4% versus 0.3%). Prevalence was highest amongst those living in very remote areas, both overall (2.2%) and within the birth cohort eligible for HBV vaccination. CONCLUSIONS: Hepatitis B virus prevalence in Northern Territory Aboriginal and Torres Strait Islander women appears to be declining as more individuals vaccinated as part of infant vaccination programs reach adulthood. Prevalence remains highest in remote areas, highlighting the importance of ongoing monitoring and of promoting vaccination in these regions.en
dc.subject*Hepatitis B/epidemiologyen
dc.subjectImmunization Programsen
dc.subjectInfant, Newbornen
dc.subject*Native Hawaiian or Other Pacific Islanderen
dc.subjectNorthern Territory/epidemiologyen
dc.titleHepatitis B prevalence in women giving birth in the Northern Territory, Australia, 2005-2015.en
dc.typeJournal Articleen
dc.identifier.journaltitleCommunicable diseases intelligence (2018)en
dc.description.affiliationThe School of Public Health, University of Queensland, Queensland, Australia.en
dc.description.affiliationThe Kirby Institute, University of NSW, Sydney, NSW, Australia.en
dc.description.affiliationMenzies School of Health Research, Charles Darwin University, Darwin, Australia.en
dc.description.affiliationVictorian Infectious Diseases Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.en
dc.description.affiliationCentre for Disease Control, Public Health Unit, Top End Health Service, Northern Territory Government Department of Health, Darwin, Northern Territory, Australia.en
dc.description.affiliationDepartment of Health, Northern Territory Government, Darwin, Northern Territory, Australia.en
dc.description.affiliationSchool of Public Health and Community Medicine, UNSW, Sydney, NSW, Australia.en
local.issue.number2209-6051 (Electronic)-
local.issue.number2209-6051 (Linking)-
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing


PubMed References

Who's citing